nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—ABCB1—ulcerative colitis	0.188	1	CbGaD
Buprenorphine—CYP2A6—Nicotine—ulcerative colitis	0.0432	0.0733	CbGbCtD
Buprenorphine—ABCG2—Sulfasalazine—ulcerative colitis	0.0311	0.0528	CbGbCtD
Buprenorphine—CYP2A6—Prednisolone—ulcerative colitis	0.0284	0.0482	CbGbCtD
Buprenorphine—ABCG2—Hydrocortisone—ulcerative colitis	0.0249	0.0423	CbGbCtD
Buprenorphine—CYP2C8—Nicotine—ulcerative colitis	0.0213	0.0361	CbGbCtD
Buprenorphine—CYP3A4—Budesonide—ulcerative colitis	0.0198	0.0337	CbGbCtD
Buprenorphine—CYP2C8—Cholecalciferol—ulcerative colitis	0.0191	0.0324	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Hydrocortisone—ulcerative colitis	0.0184	0.0313	CbGbCtD
Buprenorphine—CYP3A7—Hydrocortisone—ulcerative colitis	0.0184	0.0313	CbGbCtD
Buprenorphine—CYP2C19—Nicotine—ulcerative colitis	0.0179	0.0303	CbGbCtD
Buprenorphine—CYP3A5—Sulfasalazine—ulcerative colitis	0.0172	0.0292	CbGbCtD
Buprenorphine—CYP2A6—Dexamethasone—ulcerative colitis	0.0168	0.0284	CbGbCtD
Buprenorphine—CYP1A2—Nicotine—ulcerative colitis	0.0165	0.028	CbGbCtD
Buprenorphine—CYP2C19—Cholecalciferol—ulcerative colitis	0.016	0.0272	CbGbCtD
Buprenorphine—ABCG2—Dexamethasone—ulcerative colitis	0.0155	0.0263	CbGbCtD
Buprenorphine—CYP2C9—Nicotine—ulcerative colitis	0.0148	0.0252	CbGbCtD
Buprenorphine—ABCB1—Methylprednisolone—ulcerative colitis	0.0148	0.0251	CbGbCtD
Buprenorphine—CYP3A5—Hydrocortisone—ulcerative colitis	0.0138	0.0235	CbGbCtD
Buprenorphine—CYP2D6—Nicotine—ulcerative colitis	0.0136	0.023	CbGbCtD
Buprenorphine—CYP2C9—Cholecalciferol—ulcerative colitis	0.0133	0.0226	CbGbCtD
Buprenorphine—CYP2C8—Hydrocortisone—ulcerative colitis	0.0133	0.0226	CbGbCtD
Buprenorphine—CYP2D6—Cholecalciferol—ulcerative colitis	0.0122	0.0207	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Dexamethasone—ulcerative colitis	0.0115	0.0194	CbGbCtD
Buprenorphine—CYP3A7—Dexamethasone—ulcerative colitis	0.0115	0.0194	CbGbCtD
Buprenorphine—CYP2C19—Prednisone—ulcerative colitis	0.0111	0.0188	CbGbCtD
Buprenorphine—ABCB1—Betamethasone—ulcerative colitis	0.00961	0.0163	CbGbCtD
Buprenorphine—ABCB1—Prednisolone—ulcerative colitis	0.00948	0.0161	CbGbCtD
Buprenorphine—ABCB1—Hydrocortisone—ulcerative colitis	0.00899	0.0153	CbGbCtD
Buprenorphine—ABCB1—Prednisone—ulcerative colitis	0.00896	0.0152	CbGbCtD
Buprenorphine—CYP3A4—Methylprednisolone—ulcerative colitis	0.00886	0.015	CbGbCtD
Buprenorphine—CYP3A4—Nicotine—ulcerative colitis	0.00863	0.0147	CbGbCtD
Buprenorphine—CYP3A5—Dexamethasone—ulcerative colitis	0.00859	0.0146	CbGbCtD
Buprenorphine—CYP2C8—Dexamethasone—ulcerative colitis	0.00826	0.014	CbGbCtD
Buprenorphine—CYP3A4—Cholecalciferol—ulcerative colitis	0.00774	0.0131	CbGbCtD
Buprenorphine—CYP2C19—Dexamethasone—ulcerative colitis	0.00693	0.0118	CbGbCtD
Buprenorphine—CYP3A4—Triamcinolone—ulcerative colitis	0.00671	0.0114	CbGbCtD
Buprenorphine—CYP2C9—Dexamethasone—ulcerative colitis	0.00576	0.00978	CbGbCtD
Buprenorphine—CYP3A4—Betamethasone—ulcerative colitis	0.00576	0.00978	CbGbCtD
Buprenorphine—CYP3A4—Prednisolone—ulcerative colitis	0.00568	0.00965	CbGbCtD
Buprenorphine—ABCB1—Dexamethasone—ulcerative colitis	0.00559	0.00949	CbGbCtD
Buprenorphine—CYP3A4—Hydrocortisone—ulcerative colitis	0.00539	0.00915	CbGbCtD
Buprenorphine—CYP3A4—Prednisone—ulcerative colitis	0.00537	0.00911	CbGbCtD
Buprenorphine—CYP2D6—Dexamethasone—ulcerative colitis	0.00527	0.00894	CbGbCtD
Buprenorphine—CYP3A4—Dexamethasone—ulcerative colitis	0.00335	0.00569	CbGbCtD
Buprenorphine—Naloxone—TLR4—ulcerative colitis	0.00264	0.711	CrCbGaD
Buprenorphine—Naltrexone—ABCB1—ulcerative colitis	0.000431	0.116	CrCbGaD
Buprenorphine—Naloxone—ALB—ulcerative colitis	0.000329	0.0887	CrCbGaD
Buprenorphine—Naloxone—ABCB1—ulcerative colitis	0.000314	0.0847	CrCbGaD
Buprenorphine—Myalgia—Triamcinolone—ulcerative colitis	0.000102	0.000592	CcSEcCtD
Buprenorphine—Vomiting—Azathioprine—ulcerative colitis	0.000102	0.000591	CcSEcCtD
Buprenorphine—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000102	0.000591	CcSEcCtD
Buprenorphine—Myalgia—Methylprednisolone—ulcerative colitis	0.000102	0.00059	CcSEcCtD
Buprenorphine—Arthralgia—Methylprednisolone—ulcerative colitis	0.000102	0.00059	CcSEcCtD
Buprenorphine—Eye disorder—Prednisone—ulcerative colitis	0.000102	0.00059	CcSEcCtD
Buprenorphine—Anxiety—Methylprednisolone—ulcerative colitis	0.000101	0.000588	CcSEcCtD
Buprenorphine—Tachycardia—Hydrocortisone—ulcerative colitis	0.000101	0.000588	CcSEcCtD
Buprenorphine—Rash—Azathioprine—ulcerative colitis	0.000101	0.000586	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000101	0.000586	CcSEcCtD
Buprenorphine—Dermatitis—Azathioprine—ulcerative colitis	0.000101	0.000586	CcSEcCtD
Buprenorphine—Flushing—Prednisone—ulcerative colitis	0.000101	0.000586	CcSEcCtD
Buprenorphine—Skin disorder—Hydrocortisone—ulcerative colitis	0.000101	0.000585	CcSEcCtD
Buprenorphine—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.000101	0.000585	CcSEcCtD
Buprenorphine—Ill-defined disorder—Betamethasone—ulcerative colitis	0.000101	0.000585	CcSEcCtD
Buprenorphine—Discomfort—Triamcinolone—ulcerative colitis	0.000101	0.000585	CcSEcCtD
Buprenorphine—Discomfort—Methylprednisolone—ulcerative colitis	0.0001	0.000583	CcSEcCtD
Buprenorphine—Headache—Azathioprine—ulcerative colitis	0.0001	0.000583	CcSEcCtD
Buprenorphine—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.0001	0.000582	CcSEcCtD
Buprenorphine—Diarrhoea—Mesalazine—ulcerative colitis	9.98e-05	0.00058	CcSEcCtD
Buprenorphine—Dry mouth—Triamcinolone—ulcerative colitis	9.96e-05	0.000579	CcSEcCtD
Buprenorphine—Angioedema—Dexamethasone—ulcerative colitis	9.92e-05	0.000576	CcSEcCtD
Buprenorphine—Angioedema—Betamethasone—ulcerative colitis	9.92e-05	0.000576	CcSEcCtD
Buprenorphine—Anorexia—Hydrocortisone—ulcerative colitis	9.89e-05	0.000574	CcSEcCtD
Buprenorphine—Angiopathy—Prednisone—ulcerative colitis	9.85e-05	0.000572	CcSEcCtD
Buprenorphine—Confusional state—Methylprednisolone—ulcerative colitis	9.83e-05	0.000571	CcSEcCtD
Buprenorphine—Immune system disorder—Prednisone—ulcerative colitis	9.81e-05	0.00057	CcSEcCtD
Buprenorphine—Malaise—Dexamethasone—ulcerative colitis	9.79e-05	0.000569	CcSEcCtD
Buprenorphine—Malaise—Betamethasone—ulcerative colitis	9.79e-05	0.000569	CcSEcCtD
Buprenorphine—Anaphylactic shock—Triamcinolone—ulcerative colitis	9.77e-05	0.000567	CcSEcCtD
Buprenorphine—Oedema—Triamcinolone—ulcerative colitis	9.77e-05	0.000567	CcSEcCtD
Buprenorphine—Vertigo—Dexamethasone—ulcerative colitis	9.75e-05	0.000567	CcSEcCtD
Buprenorphine—Vertigo—Betamethasone—ulcerative colitis	9.75e-05	0.000567	CcSEcCtD
Buprenorphine—Anaphylactic shock—Methylprednisolone—ulcerative colitis	9.74e-05	0.000566	CcSEcCtD
Buprenorphine—Syncope—Dexamethasone—ulcerative colitis	9.74e-05	0.000566	CcSEcCtD
Buprenorphine—Syncope—Betamethasone—ulcerative colitis	9.74e-05	0.000566	CcSEcCtD
Buprenorphine—Infection—Triamcinolone—ulcerative colitis	9.7e-05	0.000564	CcSEcCtD
Buprenorphine—Hypotension—Hydrocortisone—ulcerative colitis	9.69e-05	0.000563	CcSEcCtD
Buprenorphine—Infection—Methylprednisolone—ulcerative colitis	9.68e-05	0.000562	CcSEcCtD
Buprenorphine—Dizziness—Mesalazine—ulcerative colitis	9.65e-05	0.00056	CcSEcCtD
Buprenorphine—Shock—Triamcinolone—ulcerative colitis	9.61e-05	0.000558	CcSEcCtD
Buprenorphine—Insomnia—Prednisolone—ulcerative colitis	9.61e-05	0.000558	CcSEcCtD
Buprenorphine—Shock—Methylprednisolone—ulcerative colitis	9.59e-05	0.000557	CcSEcCtD
Buprenorphine—Nervous system disorder—Methylprednisolone—ulcerative colitis	9.56e-05	0.000555	CcSEcCtD
Buprenorphine—Loss of consciousness—Betamethasone—ulcerative colitis	9.54e-05	0.000554	CcSEcCtD
Buprenorphine—Loss of consciousness—Dexamethasone—ulcerative colitis	9.54e-05	0.000554	CcSEcCtD
Buprenorphine—Paraesthesia—Prednisolone—ulcerative colitis	9.54e-05	0.000554	CcSEcCtD
Buprenorphine—Tachycardia—Triamcinolone—ulcerative colitis	9.53e-05	0.000554	CcSEcCtD
Buprenorphine—Mental disorder—Prednisone—ulcerative colitis	9.52e-05	0.000553	CcSEcCtD
Buprenorphine—Nausea—Azathioprine—ulcerative colitis	9.51e-05	0.000552	CcSEcCtD
Buprenorphine—Tachycardia—Methylprednisolone—ulcerative colitis	9.51e-05	0.000552	CcSEcCtD
Buprenorphine—Skin disorder—Methylprednisolone—ulcerative colitis	9.46e-05	0.00055	CcSEcCtD
Buprenorphine—Malnutrition—Prednisone—ulcerative colitis	9.46e-05	0.000549	CcSEcCtD
Buprenorphine—Erythema—Prednisone—ulcerative colitis	9.46e-05	0.000549	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	9.45e-05	0.000549	CcSEcCtD
Buprenorphine—Hyperhidrosis—Triamcinolone—ulcerative colitis	9.44e-05	0.000548	CcSEcCtD
Buprenorphine—Hyperhidrosis—Methylprednisolone—ulcerative colitis	9.42e-05	0.000547	CcSEcCtD
Buprenorphine—Convulsion—Betamethasone—ulcerative colitis	9.41e-05	0.000546	CcSEcCtD
Buprenorphine—Convulsion—Dexamethasone—ulcerative colitis	9.41e-05	0.000546	CcSEcCtD
Buprenorphine—Insomnia—Hydrocortisone—ulcerative colitis	9.38e-05	0.000545	CcSEcCtD
Buprenorphine—Hypertension—Dexamethasone—ulcerative colitis	9.37e-05	0.000545	CcSEcCtD
Buprenorphine—Hypertension—Betamethasone—ulcerative colitis	9.37e-05	0.000545	CcSEcCtD
Buprenorphine—Paraesthesia—Hydrocortisone—ulcerative colitis	9.31e-05	0.000541	CcSEcCtD
Buprenorphine—Vomiting—Mesalazine—ulcerative colitis	9.27e-05	0.000539	CcSEcCtD
Buprenorphine—Myalgia—Dexamethasone—ulcerative colitis	9.24e-05	0.000537	CcSEcCtD
Buprenorphine—Myalgia—Betamethasone—ulcerative colitis	9.24e-05	0.000537	CcSEcCtD
Buprenorphine—Anxiety—Betamethasone—ulcerative colitis	9.21e-05	0.000535	CcSEcCtD
Buprenorphine—Anxiety—Dexamethasone—ulcerative colitis	9.21e-05	0.000535	CcSEcCtD
Buprenorphine—Rash—Mesalazine—ulcerative colitis	9.2e-05	0.000534	CcSEcCtD
Buprenorphine—Dermatitis—Mesalazine—ulcerative colitis	9.19e-05	0.000534	CcSEcCtD
Buprenorphine—Headache—Mesalazine—ulcerative colitis	9.14e-05	0.000531	CcSEcCtD
Buprenorphine—Discomfort—Betamethasone—ulcerative colitis	9.13e-05	0.000531	CcSEcCtD
Buprenorphine—Discomfort—Dexamethasone—ulcerative colitis	9.13e-05	0.000531	CcSEcCtD
Buprenorphine—Dyspepsia—Hydrocortisone—ulcerative colitis	9.13e-05	0.00053	CcSEcCtD
Buprenorphine—Hypotension—Methylprednisolone—ulcerative colitis	9.11e-05	0.000529	CcSEcCtD
Buprenorphine—Pain—Prednisolone—ulcerative colitis	9.08e-05	0.000528	CcSEcCtD
Buprenorphine—Decreased appetite—Hydrocortisone—ulcerative colitis	9.02e-05	0.000524	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	8.95e-05	0.00052	CcSEcCtD
Buprenorphine—Fatigue—Hydrocortisone—ulcerative colitis	8.94e-05	0.000519	CcSEcCtD
Buprenorphine—Vision blurred—Prednisone—ulcerative colitis	8.91e-05	0.000518	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	8.9e-05	0.000517	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	8.88e-05	0.000516	CcSEcCtD
Buprenorphine—Pain—Hydrocortisone—ulcerative colitis	8.87e-05	0.000515	CcSEcCtD
Buprenorphine—Anaphylactic shock—Dexamethasone—ulcerative colitis	8.86e-05	0.000515	CcSEcCtD
Buprenorphine—Oedema—Dexamethasone—ulcerative colitis	8.86e-05	0.000515	CcSEcCtD
Buprenorphine—Oedema—Betamethasone—ulcerative colitis	8.86e-05	0.000515	CcSEcCtD
Buprenorphine—Anaphylactic shock—Betamethasone—ulcerative colitis	8.86e-05	0.000515	CcSEcCtD
Buprenorphine—Insomnia—Triamcinolone—ulcerative colitis	8.83e-05	0.000513	CcSEcCtD
Buprenorphine—Insomnia—Methylprednisolone—ulcerative colitis	8.81e-05	0.000512	CcSEcCtD
Buprenorphine—Infection—Dexamethasone—ulcerative colitis	8.8e-05	0.000511	CcSEcCtD
Buprenorphine—Infection—Betamethasone—ulcerative colitis	8.8e-05	0.000511	CcSEcCtD
Buprenorphine—Ill-defined disorder—Prednisone—ulcerative colitis	8.77e-05	0.00051	CcSEcCtD
Buprenorphine—Paraesthesia—Triamcinolone—ulcerative colitis	8.77e-05	0.000509	CcSEcCtD
Buprenorphine—Feeling abnormal—Prednisolone—ulcerative colitis	8.75e-05	0.000508	CcSEcCtD
Buprenorphine—Paraesthesia—Methylprednisolone—ulcerative colitis	8.75e-05	0.000508	CcSEcCtD
Buprenorphine—Shock—Dexamethasone—ulcerative colitis	8.72e-05	0.000506	CcSEcCtD
Buprenorphine—Shock—Betamethasone—ulcerative colitis	8.72e-05	0.000506	CcSEcCtD
Buprenorphine—Dyspnoea—Triamcinolone—ulcerative colitis	8.71e-05	0.000506	CcSEcCtD
Buprenorphine—Nervous system disorder—Dexamethasone—ulcerative colitis	8.69e-05	0.000505	CcSEcCtD
Buprenorphine—Nervous system disorder—Betamethasone—ulcerative colitis	8.69e-05	0.000505	CcSEcCtD
Buprenorphine—Agitation—Prednisone—ulcerative colitis	8.69e-05	0.000505	CcSEcCtD
Buprenorphine—Nausea—Mesalazine—ulcerative colitis	8.66e-05	0.000503	CcSEcCtD
Buprenorphine—Tachycardia—Dexamethasone—ulcerative colitis	8.65e-05	0.000502	CcSEcCtD
Buprenorphine—Tachycardia—Betamethasone—ulcerative colitis	8.65e-05	0.000502	CcSEcCtD
Buprenorphine—Angioedema—Prednisone—ulcerative colitis	8.64e-05	0.000502	CcSEcCtD
Buprenorphine—Dyspepsia—Triamcinolone—ulcerative colitis	8.6e-05	0.000499	CcSEcCtD
Buprenorphine—Dyspepsia—Methylprednisolone—ulcerative colitis	8.58e-05	0.000498	CcSEcCtD
Buprenorphine—Hyperhidrosis—Betamethasone—ulcerative colitis	8.57e-05	0.000498	CcSEcCtD
Buprenorphine—Hyperhidrosis—Dexamethasone—ulcerative colitis	8.57e-05	0.000498	CcSEcCtD
Buprenorphine—Feeling abnormal—Hydrocortisone—ulcerative colitis	8.55e-05	0.000496	CcSEcCtD
Buprenorphine—Malaise—Prednisone—ulcerative colitis	8.53e-05	0.000495	CcSEcCtD
Buprenorphine—Vertigo—Prednisone—ulcerative colitis	8.5e-05	0.000493	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	8.48e-05	0.000493	CcSEcCtD
Buprenorphine—Syncope—Prednisone—ulcerative colitis	8.48e-05	0.000493	CcSEcCtD
Buprenorphine—Anorexia—Betamethasone—ulcerative colitis	8.45e-05	0.000491	CcSEcCtD
Buprenorphine—Anorexia—Dexamethasone—ulcerative colitis	8.45e-05	0.000491	CcSEcCtD
Buprenorphine—Urticaria—Prednisolone—ulcerative colitis	8.44e-05	0.00049	CcSEcCtD
Buprenorphine—Fatigue—Triamcinolone—ulcerative colitis	8.42e-05	0.000489	CcSEcCtD
Buprenorphine—Fatigue—Methylprednisolone—ulcerative colitis	8.4e-05	0.000488	CcSEcCtD
Buprenorphine—Pain—Triamcinolone—ulcerative colitis	8.35e-05	0.000485	CcSEcCtD
Buprenorphine—Loss of consciousness—Prednisone—ulcerative colitis	8.31e-05	0.000483	CcSEcCtD
Buprenorphine—Hypotension—Dexamethasone—ulcerative colitis	8.28e-05	0.000481	CcSEcCtD
Buprenorphine—Hypotension—Betamethasone—ulcerative colitis	8.28e-05	0.000481	CcSEcCtD
Buprenorphine—Urticaria—Hydrocortisone—ulcerative colitis	8.24e-05	0.000479	CcSEcCtD
Buprenorphine—Body temperature increased—Hydrocortisone—ulcerative colitis	8.2e-05	0.000476	CcSEcCtD
Buprenorphine—Abdominal pain—Hydrocortisone—ulcerative colitis	8.2e-05	0.000476	CcSEcCtD
Buprenorphine—Convulsion—Prednisone—ulcerative colitis	8.19e-05	0.000476	CcSEcCtD
Buprenorphine—Hypertension—Prednisone—ulcerative colitis	8.16e-05	0.000474	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	8.07e-05	0.000469	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	8.07e-05	0.000469	CcSEcCtD
Buprenorphine—Arthralgia—Prednisone—ulcerative colitis	8.05e-05	0.000468	CcSEcCtD
Buprenorphine—Myalgia—Prednisone—ulcerative colitis	8.05e-05	0.000468	CcSEcCtD
Buprenorphine—Feeling abnormal—Triamcinolone—ulcerative colitis	8.05e-05	0.000467	CcSEcCtD
Buprenorphine—Feeling abnormal—Methylprednisolone—ulcerative colitis	8.03e-05	0.000466	CcSEcCtD
Buprenorphine—Anxiety—Prednisone—ulcerative colitis	8.02e-05	0.000466	CcSEcCtD
Buprenorphine—Insomnia—Dexamethasone—ulcerative colitis	8.01e-05	0.000466	CcSEcCtD
Buprenorphine—Insomnia—Betamethasone—ulcerative colitis	8.01e-05	0.000466	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	7.99e-05	0.000464	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	7.97e-05	0.000463	CcSEcCtD
Buprenorphine—Paraesthesia—Dexamethasone—ulcerative colitis	7.96e-05	0.000462	CcSEcCtD
Buprenorphine—Paraesthesia—Betamethasone—ulcerative colitis	7.96e-05	0.000462	CcSEcCtD
Buprenorphine—Discomfort—Prednisone—ulcerative colitis	7.95e-05	0.000462	CcSEcCtD
Buprenorphine—Hypersensitivity—Prednisolone—ulcerative colitis	7.82e-05	0.000454	CcSEcCtD
Buprenorphine—Dyspepsia—Dexamethasone—ulcerative colitis	7.8e-05	0.000453	CcSEcCtD
Buprenorphine—Dyspepsia—Betamethasone—ulcerative colitis	7.8e-05	0.000453	CcSEcCtD
Buprenorphine—Urticaria—Triamcinolone—ulcerative colitis	7.76e-05	0.000451	CcSEcCtD
Buprenorphine—Urticaria—Methylprednisolone—ulcerative colitis	7.74e-05	0.00045	CcSEcCtD
Buprenorphine—Body temperature increased—Triamcinolone—ulcerative colitis	7.72e-05	0.000448	CcSEcCtD
Buprenorphine—Oedema—Prednisone—ulcerative colitis	7.72e-05	0.000448	CcSEcCtD
Buprenorphine—Anaphylactic shock—Prednisone—ulcerative colitis	7.72e-05	0.000448	CcSEcCtD
Buprenorphine—Abdominal pain—Methylprednisolone—ulcerative colitis	7.7e-05	0.000447	CcSEcCtD
Buprenorphine—Decreased appetite—Betamethasone—ulcerative colitis	7.7e-05	0.000447	CcSEcCtD
Buprenorphine—Decreased appetite—Dexamethasone—ulcerative colitis	7.7e-05	0.000447	CcSEcCtD
Buprenorphine—Infection—Prednisone—ulcerative colitis	7.67e-05	0.000445	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Betamethasone—ulcerative colitis	7.65e-05	0.000444	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	7.65e-05	0.000444	CcSEcCtD
Buprenorphine—Hypersensitivity—Hydrocortisone—ulcerative colitis	7.64e-05	0.000444	CcSEcCtD
Buprenorphine—Fatigue—Dexamethasone—ulcerative colitis	7.64e-05	0.000444	CcSEcCtD
Buprenorphine—Fatigue—Betamethasone—ulcerative colitis	7.64e-05	0.000444	CcSEcCtD
Buprenorphine—Shock—Prednisone—ulcerative colitis	7.59e-05	0.000441	CcSEcCtD
Buprenorphine—Pain—Dexamethasone—ulcerative colitis	7.58e-05	0.00044	CcSEcCtD
Buprenorphine—Pain—Betamethasone—ulcerative colitis	7.58e-05	0.00044	CcSEcCtD
Buprenorphine—Nervous system disorder—Prednisone—ulcerative colitis	7.57e-05	0.00044	CcSEcCtD
Buprenorphine—Tachycardia—Prednisone—ulcerative colitis	7.53e-05	0.000437	CcSEcCtD
Buprenorphine—Skin disorder—Prednisone—ulcerative colitis	7.5e-05	0.000435	CcSEcCtD
Buprenorphine—Hyperhidrosis—Prednisone—ulcerative colitis	7.46e-05	0.000433	CcSEcCtD
Buprenorphine—Asthenia—Hydrocortisone—ulcerative colitis	7.44e-05	0.000432	CcSEcCtD
Buprenorphine—Anorexia—Prednisone—ulcerative colitis	7.36e-05	0.000427	CcSEcCtD
Buprenorphine—Pruritus—Hydrocortisone—ulcerative colitis	7.34e-05	0.000426	CcSEcCtD
Buprenorphine—Feeling abnormal—Dexamethasone—ulcerative colitis	7.3e-05	0.000424	CcSEcCtD
Buprenorphine—Feeling abnormal—Betamethasone—ulcerative colitis	7.3e-05	0.000424	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Betamethasone—ulcerative colitis	7.25e-05	0.000421	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Dexamethasone—ulcerative colitis	7.25e-05	0.000421	CcSEcCtD
Buprenorphine—Hypersensitivity—Triamcinolone—ulcerative colitis	7.2e-05	0.000418	CcSEcCtD
Buprenorphine—Hypersensitivity—Methylprednisolone—ulcerative colitis	7.18e-05	0.000417	CcSEcCtD
Buprenorphine—Diarrhoea—Hydrocortisone—ulcerative colitis	7.1e-05	0.000412	CcSEcCtD
Buprenorphine—Urticaria—Betamethasone—ulcerative colitis	7.04e-05	0.000409	CcSEcCtD
Buprenorphine—Urticaria—Dexamethasone—ulcerative colitis	7.04e-05	0.000409	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Prednisone—ulcerative colitis	7.03e-05	0.000408	CcSEcCtD
Buprenorphine—Dizziness—Prednisolone—ulcerative colitis	7.02e-05	0.000408	CcSEcCtD
Buprenorphine—Asthenia—Triamcinolone—ulcerative colitis	7.01e-05	0.000407	CcSEcCtD
Buprenorphine—Body temperature increased—Betamethasone—ulcerative colitis	7e-05	0.000407	CcSEcCtD
Buprenorphine—Body temperature increased—Dexamethasone—ulcerative colitis	7e-05	0.000407	CcSEcCtD
Buprenorphine—Abdominal pain—Dexamethasone—ulcerative colitis	7e-05	0.000407	CcSEcCtD
Buprenorphine—Abdominal pain—Betamethasone—ulcerative colitis	7e-05	0.000407	CcSEcCtD
Buprenorphine—Asthenia—Methylprednisolone—ulcerative colitis	6.99e-05	0.000406	CcSEcCtD
Buprenorphine—Insomnia—Prednisone—ulcerative colitis	6.98e-05	0.000405	CcSEcCtD
Buprenorphine—Paraesthesia—Prednisone—ulcerative colitis	6.93e-05	0.000403	CcSEcCtD
Buprenorphine—Pruritus—Triamcinolone—ulcerative colitis	6.91e-05	0.000401	CcSEcCtD
Buprenorphine—Pruritus—Methylprednisolone—ulcerative colitis	6.89e-05	0.0004	CcSEcCtD
Buprenorphine—Dizziness—Hydrocortisone—ulcerative colitis	6.86e-05	0.000398	CcSEcCtD
Buprenorphine—Dyspepsia—Prednisone—ulcerative colitis	6.79e-05	0.000395	CcSEcCtD
Buprenorphine—Decreased appetite—Prednisone—ulcerative colitis	6.71e-05	0.00039	CcSEcCtD
Buprenorphine—Rash—Prednisolone—ulcerative colitis	6.7e-05	0.000389	CcSEcCtD
Buprenorphine—Dermatitis—Prednisolone—ulcerative colitis	6.69e-05	0.000389	CcSEcCtD
Buprenorphine—Diarrhoea—Methylprednisolone—ulcerative colitis	6.67e-05	0.000387	CcSEcCtD
Buprenorphine—Fatigue—Prednisone—ulcerative colitis	6.65e-05	0.000386	CcSEcCtD
Buprenorphine—Headache—Prednisolone—ulcerative colitis	6.65e-05	0.000386	CcSEcCtD
Buprenorphine—Constipation—Prednisone—ulcerative colitis	6.6e-05	0.000383	CcSEcCtD
Buprenorphine—Vomiting—Hydrocortisone—ulcerative colitis	6.59e-05	0.000383	CcSEcCtD
Buprenorphine—Rash—Hydrocortisone—ulcerative colitis	6.54e-05	0.00038	CcSEcCtD
Buprenorphine—Dermatitis—Hydrocortisone—ulcerative colitis	6.53e-05	0.00038	CcSEcCtD
Buprenorphine—Headache—Hydrocortisone—ulcerative colitis	6.5e-05	0.000377	CcSEcCtD
Buprenorphine—Dizziness—Triamcinolone—ulcerative colitis	6.46e-05	0.000375	CcSEcCtD
Buprenorphine—Dizziness—Methylprednisolone—ulcerative colitis	6.44e-05	0.000374	CcSEcCtD
Buprenorphine—Feeling abnormal—Prednisone—ulcerative colitis	6.36e-05	0.000369	CcSEcCtD
Buprenorphine—Asthenia—Dexamethasone—ulcerative colitis	6.36e-05	0.000369	CcSEcCtD
Buprenorphine—Asthenia—Betamethasone—ulcerative colitis	6.36e-05	0.000369	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Prednisone—ulcerative colitis	6.31e-05	0.000367	CcSEcCtD
Buprenorphine—Nausea—Prednisolone—ulcerative colitis	6.31e-05	0.000366	CcSEcCtD
Buprenorphine—Pruritus—Betamethasone—ulcerative colitis	6.27e-05	0.000364	CcSEcCtD
Buprenorphine—Pruritus—Dexamethasone—ulcerative colitis	6.27e-05	0.000364	CcSEcCtD
Buprenorphine—Vomiting—Triamcinolone—ulcerative colitis	6.21e-05	0.000361	CcSEcCtD
Buprenorphine—Vomiting—Methylprednisolone—ulcerative colitis	6.2e-05	0.00036	CcSEcCtD
Buprenorphine—Nausea—Hydrocortisone—ulcerative colitis	6.16e-05	0.000358	CcSEcCtD
Buprenorphine—Rash—Triamcinolone—ulcerative colitis	6.16e-05	0.000358	CcSEcCtD
Buprenorphine—Dermatitis—Triamcinolone—ulcerative colitis	6.15e-05	0.000357	CcSEcCtD
Buprenorphine—Rash—Methylprednisolone—ulcerative colitis	6.14e-05	0.000357	CcSEcCtD
Buprenorphine—Dermatitis—Methylprednisolone—ulcerative colitis	6.14e-05	0.000357	CcSEcCtD
Buprenorphine—Urticaria—Prednisone—ulcerative colitis	6.13e-05	0.000356	CcSEcCtD
Buprenorphine—Headache—Triamcinolone—ulcerative colitis	6.12e-05	0.000355	CcSEcCtD
Buprenorphine—Headache—Methylprednisolone—ulcerative colitis	6.1e-05	0.000355	CcSEcCtD
Buprenorphine—Abdominal pain—Prednisone—ulcerative colitis	6.1e-05	0.000354	CcSEcCtD
Buprenorphine—Body temperature increased—Prednisone—ulcerative colitis	6.1e-05	0.000354	CcSEcCtD
Buprenorphine—Diarrhoea—Betamethasone—ulcerative colitis	6.06e-05	0.000352	CcSEcCtD
Buprenorphine—Diarrhoea—Dexamethasone—ulcerative colitis	6.06e-05	0.000352	CcSEcCtD
Buprenorphine—Dizziness—Dexamethasone—ulcerative colitis	5.86e-05	0.00034	CcSEcCtD
Buprenorphine—Dizziness—Betamethasone—ulcerative colitis	5.86e-05	0.00034	CcSEcCtD
Buprenorphine—Nausea—Triamcinolone—ulcerative colitis	5.8e-05	0.000337	CcSEcCtD
Buprenorphine—Nausea—Methylprednisolone—ulcerative colitis	5.79e-05	0.000336	CcSEcCtD
Buprenorphine—Hypersensitivity—Prednisone—ulcerative colitis	5.69e-05	0.00033	CcSEcCtD
Buprenorphine—Vomiting—Dexamethasone—ulcerative colitis	5.63e-05	0.000327	CcSEcCtD
Buprenorphine—Vomiting—Betamethasone—ulcerative colitis	5.63e-05	0.000327	CcSEcCtD
Buprenorphine—Rash—Dexamethasone—ulcerative colitis	5.59e-05	0.000325	CcSEcCtD
Buprenorphine—Rash—Betamethasone—ulcerative colitis	5.59e-05	0.000325	CcSEcCtD
Buprenorphine—Dermatitis—Betamethasone—ulcerative colitis	5.58e-05	0.000324	CcSEcCtD
Buprenorphine—Dermatitis—Dexamethasone—ulcerative colitis	5.58e-05	0.000324	CcSEcCtD
Buprenorphine—Headache—Betamethasone—ulcerative colitis	5.55e-05	0.000322	CcSEcCtD
Buprenorphine—Headache—Dexamethasone—ulcerative colitis	5.55e-05	0.000322	CcSEcCtD
Buprenorphine—Asthenia—Prednisone—ulcerative colitis	5.54e-05	0.000322	CcSEcCtD
Buprenorphine—Pruritus—Prednisone—ulcerative colitis	5.46e-05	0.000317	CcSEcCtD
Buprenorphine—Diarrhoea—Prednisone—ulcerative colitis	5.28e-05	0.000307	CcSEcCtD
Buprenorphine—Nausea—Betamethasone—ulcerative colitis	5.26e-05	0.000306	CcSEcCtD
Buprenorphine—Nausea—Dexamethasone—ulcerative colitis	5.26e-05	0.000306	CcSEcCtD
Buprenorphine—Dizziness—Prednisone—ulcerative colitis	5.1e-05	0.000296	CcSEcCtD
Buprenorphine—Vomiting—Prednisone—ulcerative colitis	4.91e-05	0.000285	CcSEcCtD
Buprenorphine—Rash—Prednisone—ulcerative colitis	4.87e-05	0.000283	CcSEcCtD
Buprenorphine—Dermatitis—Prednisone—ulcerative colitis	4.86e-05	0.000282	CcSEcCtD
Buprenorphine—Headache—Prednisone—ulcerative colitis	4.83e-05	0.000281	CcSEcCtD
Buprenorphine—Nausea—Prednisone—ulcerative colitis	4.58e-05	0.000266	CcSEcCtD
Buprenorphine—CYP2A6—NRF2 pathway—TGFB1—ulcerative colitis	2.57e-05	0.000541	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—GHRL—ulcerative colitis	2.56e-05	0.000539	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—PTGER4—ulcerative colitis	2.54e-05	0.000534	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—ADRB2—ulcerative colitis	2.5e-05	0.000528	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	2.5e-05	0.000527	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CXCR2—ulcerative colitis	2.44e-05	0.000515	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—CXCL8—ulcerative colitis	2.44e-05	0.000514	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—ADCY5—ulcerative colitis	2.42e-05	0.000511	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CCL20—ulcerative colitis	2.4e-05	0.000506	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	2.38e-05	0.0005	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—TNF—ulcerative colitis	2.33e-05	0.000492	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—GHRL—ulcerative colitis	2.32e-05	0.000489	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CXCR1—ulcerative colitis	2.31e-05	0.000487	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CCR6—ulcerative colitis	2.3e-05	0.000484	CbGpPWpGaD
Buprenorphine—ABCG2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	2.29e-05	0.000482	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—PTGS1—ulcerative colitis	2.28e-05	0.000481	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CHP1—ulcerative colitis	2.28e-05	0.00048	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—ADRB2—ulcerative colitis	2.27e-05	0.000479	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—DLD—ulcerative colitis	2.27e-05	0.000478	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—GNA12—ulcerative colitis	2.26e-05	0.000476	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CALM3—ulcerative colitis	2.25e-05	0.000474	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—ADCY5—ulcerative colitis	2.2e-05	0.000464	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—MAML2—ulcerative colitis	2.18e-05	0.000459	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.15e-05	0.000453	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CXCR2—ulcerative colitis	2.14e-05	0.000451	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—CXCL8—ulcerative colitis	2.14e-05	0.000451	CbGpPWpGaD
Buprenorphine—ABCG2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	2.14e-05	0.00045	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.13e-05	0.00045	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—ADCY5—ulcerative colitis	2.13e-05	0.000448	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—ADRB2—ulcerative colitis	2.12e-05	0.000446	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—CALM3—ulcerative colitis	2.06e-05	0.000433	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CHP1—ulcerative colitis	2.03e-05	0.000428	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCL20—ulcerative colitis	2.03e-05	0.000428	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—PTGER4—ulcerative colitis	2.02e-05	0.000426	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CCR6—ulcerative colitis	2.01e-05	0.000424	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CHP1—ulcerative colitis	1.98e-05	0.000418	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.97e-05	0.000416	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—DLD—ulcerative colitis	1.97e-05	0.000414	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—ADCY5—ulcerative colitis	1.93e-05	0.000407	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—ADRB2—ulcerative colitis	1.92e-05	0.000405	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—GNA12—ulcerative colitis	1.91e-05	0.000402	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MAML2—ulcerative colitis	1.91e-05	0.000402	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.9e-05	0.000401	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—JAK2—ulcerative colitis	1.9e-05	0.0004	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CHP1—ulcerative colitis	1.87e-05	0.000394	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CHP1—ulcerative colitis	1.85e-05	0.00039	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—GHRL—ulcerative colitis	1.85e-05	0.00039	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—RELA—ulcerative colitis	1.84e-05	0.000388	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CXCR2—ulcerative colitis	1.81e-05	0.000381	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—CXCL8—ulcerative colitis	1.81e-05	0.000381	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PTGS1—ulcerative colitis	1.8e-05	0.00038	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—ADCY5—ulcerative colitis	1.8e-05	0.000379	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CALM3—ulcerative colitis	1.79e-05	0.000378	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.78e-05	0.000374	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—PTGER4—ulcerative colitis	1.77e-05	0.000373	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—RIPK2—ulcerative colitis	1.77e-05	0.000372	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—DLD—ulcerative colitis	1.75e-05	0.00037	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.74e-05	0.000366	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—CXCL8—ulcerative colitis	1.73e-05	0.000365	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—DLD—ulcerative colitis	1.71e-05	0.000361	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	1.71e-05	0.000359	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCR6—ulcerative colitis	1.7e-05	0.000359	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—IL2—ulcerative colitis	1.66e-05	0.000349	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—IL6—ulcerative colitis	1.65e-05	0.000347	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—ADCY5—ulcerative colitis	1.63e-05	0.000344	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—CALM3—ulcerative colitis	1.62e-05	0.000342	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—GHRL—ulcerative colitis	1.62e-05	0.000342	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—DLD—ulcerative colitis	1.61e-05	0.00034	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MAML2—ulcerative colitis	1.61e-05	0.00034	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—DLD—ulcerative colitis	1.6e-05	0.000337	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—ABCB1—ulcerative colitis	1.6e-05	0.000337	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CHP1—ulcerative colitis	1.58e-05	0.000334	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CALM3—ulcerative colitis	1.57e-05	0.000331	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—MMP9—ulcerative colitis	1.57e-05	0.00033	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.55e-05	0.000327	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—NFKB1—ulcerative colitis	1.55e-05	0.000327	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—RIPK2—ulcerative colitis	1.55e-05	0.000326	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—ADRB2—ulcerative colitis	1.53e-05	0.000323	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PTGS1—ulcerative colitis	1.53e-05	0.000323	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PTGS1—ulcerative colitis	1.52e-05	0.00032	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—JAK2—ulcerative colitis	1.51e-05	0.000318	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PTGER4—ulcerative colitis	1.5e-05	0.000316	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—ADCY5—ulcerative colitis	1.49e-05	0.000314	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.48e-05	0.000313	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.48e-05	0.000312	CbGpPWpGaD
Buprenorphine—ABCG2—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.43e-05	0.000302	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—STAT3—ulcerative colitis	1.39e-05	0.000294	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PTGS1—ulcerative colitis	1.39e-05	0.000293	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—CXCL8—ulcerative colitis	1.38e-05	0.000291	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—CALM3—ulcerative colitis	1.38e-05	0.00029	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—JAK2—ulcerative colitis	1.37e-05	0.000289	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—GHRL—ulcerative colitis	1.37e-05	0.000289	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—DLD—ulcerative colitis	1.37e-05	0.000288	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—CALM3—ulcerative colitis	1.37e-05	0.000288	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—ADRB2—ulcerative colitis	1.34e-05	0.000283	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CALM3—ulcerative colitis	1.33e-05	0.00028	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—JAK2—ulcerative colitis	1.33e-05	0.000279	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—IL2—ulcerative colitis	1.32e-05	0.000278	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—RIPK2—ulcerative colitis	1.31e-05	0.000276	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—ADCY5—ulcerative colitis	1.3e-05	0.000274	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—TGFB1—ulcerative colitis	1.29e-05	0.000272	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—ABCB1—ulcerative colitis	1.26e-05	0.000266	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—CXCL8—ulcerative colitis	1.25e-05	0.000264	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CALM3—ulcerative colitis	1.25e-05	0.000264	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.23e-05	0.00026	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CHP1—ulcerative colitis	1.22e-05	0.000257	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—CXCL8—ulcerative colitis	1.21e-05	0.000255	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—JAK2—ulcerative colitis	1.2e-05	0.000254	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—IL2—ulcerative colitis	1.2e-05	0.000252	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—ADCY5—ulcerative colitis	1.18e-05	0.000248	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—IL2—ulcerative colitis	1.16e-05	0.000244	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.15e-05	0.000243	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.15e-05	0.000243	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—ADCY5—ulcerative colitis	1.14e-05	0.00024	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—ADRB2—ulcerative colitis	1.14e-05	0.000239	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—JAK2—ulcerative colitis	1.12e-05	0.000236	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—PPARG—ulcerative colitis	1.11e-05	0.000234	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—CXCL8—ulcerative colitis	1.1e-05	0.000231	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PTGS1—ulcerative colitis	1.1e-05	0.000231	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—ABCB1—ulcerative colitis	1.07e-05	0.000226	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—TP53—ulcerative colitis	1.06e-05	0.000224	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—ABCB1—ulcerative colitis	1.06e-05	0.000224	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—DLD—ulcerative colitis	1.06e-05	0.000222	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL2—ulcerative colitis	1.05e-05	0.000221	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.04e-05	0.000219	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—CXCL8—ulcerative colitis	1.02e-05	0.000215	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—JAK2—ulcerative colitis	1.02e-05	0.000214	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.02e-05	0.000214	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—ADCY5—ulcerative colitis	1e-05	0.000211	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—ALB—ulcerative colitis	1e-05	0.000211	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—ADCY5—ulcerative colitis	9.91e-06	0.000209	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CALM3—ulcerative colitis	9.88e-06	0.000208	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—IL2—ulcerative colitis	9.77e-06	0.000206	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—ABCB1—ulcerative colitis	9.74e-06	0.000205	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—IL6—ulcerative colitis	9.74e-06	0.000205	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—ADCY5—ulcerative colitis	9.64e-06	0.000203	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PTGS1—ulcerative colitis	9.5e-06	0.0002	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	9.35e-06	0.000197	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CXCL8—ulcerative colitis	9.28e-06	0.000196	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	9.28e-06	0.000195	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—ADCY5—ulcerative colitis	9.09e-06	0.000191	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL2—ulcerative colitis	8.87e-06	0.000187	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PPARG—ulcerative colitis	8.79e-06	0.000185	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—PTGS2—ulcerative colitis	8.75e-06	0.000184	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CALM3—ulcerative colitis	8.56e-06	0.00018	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PTGS1—ulcerative colitis	8.48e-06	0.000179	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	8.46e-06	0.000178	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	8.34e-06	0.000176	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PTGS1—ulcerative colitis	8.28e-06	0.000174	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	8.18e-06	0.000172	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—JAK2—ulcerative colitis	8.11e-06	0.000171	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—ALB—ulcerative colitis	7.91e-06	0.000167	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—RELA—ulcerative colitis	7.85e-06	0.000165	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PTGS1—ulcerative colitis	7.8e-06	0.000164	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	7.74e-06	0.000163	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PTGS1—ulcerative colitis	7.73e-06	0.000163	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ABCB1—ulcerative colitis	7.68e-06	0.000162	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CALM3—ulcerative colitis	7.64e-06	0.000161	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	7.61e-06	0.00016	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PPARG—ulcerative colitis	7.46e-06	0.000157	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CALM3—ulcerative colitis	7.45e-06	0.000157	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CXCL8—ulcerative colitis	7.4e-06	0.000156	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PPARG—ulcerative colitis	7.39e-06	0.000156	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	7.3e-06	0.000154	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	7.23e-06	0.000152	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ADCY5—ulcerative colitis	7.17e-06	0.000151	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—JAK2—ulcerative colitis	7.11e-06	0.00015	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL2—ulcerative colitis	7.07e-06	0.000149	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—IL6—ulcerative colitis	7.04e-06	0.000148	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CALM3—ulcerative colitis	7.02e-06	0.000148	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CALM3—ulcerative colitis	6.96e-06	0.000147	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PTGS2—ulcerative colitis	6.92e-06	0.000146	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—RELA—ulcerative colitis	6.89e-06	0.000145	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PPARG—ulcerative colitis	6.78e-06	0.000143	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—ALB—ulcerative colitis	6.71e-06	0.000141	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—MMP9—ulcerative colitis	6.69e-06	0.000141	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	6.66e-06	0.00014	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ABCB1—ulcerative colitis	6.65e-06	0.00014	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—ALB—ulcerative colitis	6.65e-06	0.00014	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—NFKB1—ulcerative colitis	6.62e-06	0.00014	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PTGS1—ulcerative colitis	6.61e-06	0.000139	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	6.5e-06	0.000137	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CXCL8—ulcerative colitis	6.49e-06	0.000137	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ADCY5—ulcerative colitis	6.21e-06	0.000131	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL2—ulcerative colitis	6.2e-06	0.000131	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL6—ulcerative colitis	6.17e-06	0.00013	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—ALB—ulcerative colitis	6.09e-06	0.000128	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—JAK2—ulcerative colitis	6.01e-06	0.000127	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—STAT3—ulcerative colitis	5.95e-06	0.000125	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CALM3—ulcerative colitis	5.95e-06	0.000125	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ABCB1—ulcerative colitis	5.94e-06	0.000125	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MMP9—ulcerative colitis	5.87e-06	0.000124	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PTGS2—ulcerative colitis	5.87e-06	0.000124	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—RELA—ulcerative colitis	5.82e-06	0.000123	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PTGS2—ulcerative colitis	5.82e-06	0.000123	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NFKB1—ulcerative colitis	5.81e-06	0.000122	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.69e-06	0.00012	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ADCY5—ulcerative colitis	5.54e-06	0.000117	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TGFB1—ulcerative colitis	5.52e-06	0.000116	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CXCL8—ulcerative colitis	5.48e-06	0.000116	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ABCB1—ulcerative colitis	5.46e-06	0.000115	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ABCB1—ulcerative colitis	5.42e-06	0.000114	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ADCY5—ulcerative colitis	5.41e-06	0.000114	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PPARG—ulcerative colitis	5.34e-06	0.000113	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PTGS2—ulcerative colitis	5.33e-06	0.000112	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL2—ulcerative colitis	5.24e-06	0.00011	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—STAT3—ulcerative colitis	5.22e-06	0.00011	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL6—ulcerative colitis	5.22e-06	0.00011	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PTGS1—ulcerative colitis	5.1e-06	0.000107	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ADCY5—ulcerative colitis	5.1e-06	0.000107	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ADCY5—ulcerative colitis	5.05e-06	0.000106	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MMP9—ulcerative colitis	4.96e-06	0.000105	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NFKB1—ulcerative colitis	4.91e-06	0.000103	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TGFB1—ulcerative colitis	4.84e-06	0.000102	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ALB—ulcerative colitis	4.81e-06	0.000101	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PPARG—ulcerative colitis	4.63e-06	9.75e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ABCB1—ulcerative colitis	4.63e-06	9.75e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CALM3—ulcerative colitis	4.59e-06	9.68e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TP53—ulcerative colitis	4.54e-06	9.57e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—STAT3—ulcerative colitis	4.41e-06	9.29e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ADCY5—ulcerative colitis	4.32e-06	9.09e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PTGS2—ulcerative colitis	4.2e-06	8.86e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ALB—ulcerative colitis	4.16e-06	8.77e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL6—ulcerative colitis	4.16e-06	8.76e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PPARG—ulcerative colitis	4.13e-06	8.7e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TGFB1—ulcerative colitis	4.09e-06	8.61e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PPARG—ulcerative colitis	4.03e-06	8.5e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TP53—ulcerative colitis	3.98e-06	8.39e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PPARG—ulcerative colitis	3.8e-06	8.01e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PPARG—ulcerative colitis	3.77e-06	7.94e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ALB—ulcerative colitis	3.72e-06	7.83e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL6—ulcerative colitis	3.65e-06	7.68e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PTGS2—ulcerative colitis	3.64e-06	7.67e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ALB—ulcerative colitis	3.63e-06	7.64e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ABCB1—ulcerative colitis	3.57e-06	7.52e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ALB—ulcerative colitis	3.42e-06	7.2e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ALB—ulcerative colitis	3.39e-06	7.14e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TP53—ulcerative colitis	3.37e-06	7.09e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ADCY5—ulcerative colitis	3.33e-06	7.02e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PTGS2—ulcerative colitis	3.25e-06	6.85e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PPARG—ulcerative colitis	3.22e-06	6.78e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PTGS2—ulcerative colitis	3.17e-06	6.68e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL6—ulcerative colitis	3.08e-06	6.49e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PTGS2—ulcerative colitis	2.99e-06	6.3e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PTGS2—ulcerative colitis	2.96e-06	6.24e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ALB—ulcerative colitis	2.9e-06	6.1e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PTGS2—ulcerative colitis	2.53e-06	5.34e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PPARG—ulcerative colitis	2.48e-06	5.23e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ALB—ulcerative colitis	2.23e-06	4.71e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PTGS2—ulcerative colitis	1.95e-06	4.12e-05	CbGpPWpGaD
